Orange biomanufacturer Cauldron raises $13.25M Series A2, no sales team disclosed
Cauldron Ferm closed $13.25M led by Main Sequence Ventures to scale hyper-fermentation tech in regional NSW. The 2022-founded biotech runs a 30,000-litre facility in Orange but hasn't disclosed sales team size, structure, or hiring plans. Worth noting for biotech sales professionals: no CRO, VP Sales, or revenue numbers public despite $19.5M total raised.